Literature DB >> 20582291

Observational study of the impact of short-term duloxetine treatment on body weight in patients with major depressive disorder: a taiwanese perspective.

Chien-Han Lai1.   

Abstract

Entities:  

Year:  2010        PMID： 20582291      PMCID： PMC2882807          DOI： 10.4088/PCC.08l00768blu

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  9 in total

1.  Perception of appetite and weight change during treatment for depression.

Authors:  M H Fernstrom; C McConaha; D J Kupfer
Journal:  Appetite       Date:  1989-08       Impact factor: 3.868

2.  Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.

Authors:  M Fava; R Judge; S L Hoog; M E Nilsson; S C Koke
Journal:  J Clin Psychiatry       Date:  2000-11       Impact factor: 4.384

3.  Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.

Authors:  Michael H Skinner; Han-Yi Kuan; Alan Pan; Korbtham Sathirakul; Mary Pat Knadler; Celedon R Gonzales; Kwee Poo Yeo; Shobha Reddy; Maggie Lim; Mosun Ayan-Oshodi; Stephen D Wise
Journal:  Clin Pharmacol Ther       Date:  2003-03       Impact factor: 6.875

4.  Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

Authors:  N Finer; S R Bloom; G S Frost; L M Banks; J Griffiths
Journal:  Diabetes Obes Metab       Date:  2000-04       Impact factor: 6.577

5.  Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies.

Authors:  Thomas N Wise; David G S Perahia; Beth A Pangallo; William G Losin; Curtis G Wiltse
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

6.  Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.

Authors:  Madelaine M Wohlreich; Craig H Mallinckrodt; Apurva Prakash; John G Watkin; William P Carter
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

7.  Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.

Authors:  J E Turcotte; G Debonnel; C de Montigny; C Hébert; P Blier
Journal:  Neuropsychopharmacology       Date:  2001-05       Impact factor: 7.853

8.  Weight gain. A side-effect of tricyclic antidepressants.

Authors:  G H Berken; D O Weinstein; W C Stern
Journal:  J Affect Disord       Date:  1984-10       Impact factor: 4.839

Review 9.  Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.